Pulling SEC filings + quote and writing the call…
ORMP
ORAMED PHARMACEUTICALS INC.
Next earnings Jul 15, 2026 · consensus $0.19 EPS
$3.96
▲ +2.06%$3.88▲ +92.68%
over 1Y
L $1.92EODHDH $4.73
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+2.1%
1W+2.1%
1M-10.4%
3M+7.5%
YTD+43.0%
1Y+92.7%
Buy
Conviction
Horizon
Medium (3–12mo)
Street · 6 analysts
Sell
Revenue grew 49.3% YoY.
The read
Quality fundamentals and an attractive price line up (~1339% below fair value) — the rarer case where both the business and the entry look good.
Sources: SEC EDGAR (CIK 0001176309, latest 10-Q filed 2026-05-19) · EODHD · as of 6/22/2026, 4:11:00 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.